BlackRock (BLK) PT Raised to $1,393 at Morgan Stanley

Morgan Stanley analyst Michael Cyprys raised the price target on BlackRock (NYSE: BLK) to $1,393.00 (from $1,368.00) while maintaining a Overweight rating.

The analyst comments "We reiterate Overweight BLK with a $1,393 PT, implying 22x ’27E EPS vs ~16.2x current at a discount to the broader market (at 19.6x) despite superior growth and margin profile and substantial capital return. We forecast mid-single-digit organic revenue growth, operating margin expansion to ~48.5% by 2028, and ~15% EPS CAGR (2025–28E). Structural tailwinds—private market democratization, retirement solutions, Aladdin/tech monetization, and digital assets—support sustained above-market growth."

You May Also Be Interested In

• Freedom Capital Starts Flutter Entertainment (FLUT) at Hold
• Taysha Gene Therapies (TSHA) PT Raised to $10 at BofA Securities
• Definium Therapeutics Inc (DFTX) PT Raised to $60 at Oppenheimer